Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.
      Google Scholar   
Citation:
Lancet Oncol vol 22 (2) 212-22
Year:
2021
Type:
Manuscript
Funding:
AFT
Endpoint:
Primary
Analysis:
Preliminary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
10
Parents:
3417  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Pfizer  
Grants:
 
Corr. Author:
 
Authors:
                                                                                         
Networks:
CA136, FL086, HEARTLAND, LAPS-CT018, LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-NY016, LAPS-TX035, METROMIN   
Study
AFT-05
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: